Analyze Diet
Journal of pharmaceutical and biomedical analysis2023; 235; 115600; doi: 10.1016/j.jpba.2023.115600

First evidence of the incorporation of daprodustat and other hypoxia-inducible factor stabilizers into equine hair by passive transfer based on segmental quantitative analysis.

Abstract: Daprodustat is a hypoxia-inducible factor prolyl hydroxylase domain (HIF-PHD) inhibitor and is used as an erythropoiesis stimulant for the treatment of anemia in humans. In general, administering daprodustat to horses will result in a lifetime ban from both equestrian sports and horseracing by the International Federation of Horseracing Authorities and the Fédération Équestre Internationale, respectively. To control the misuse/abuse of daprodustat, we conducted nasoesophageal administration of daprodustat (100 mg/day for 3 days) to three thoroughbred mares and the post-administration hair samples collected from the three horses over 6 months were analyzed to demonstrate the potential longer-term detection of daprodustat and its metabolites in hair compared with the detection times of daprodustat of 1 and 2 weeks in plasma and urine respectively. The results of the quantitative 2-cm segmental analysis showed that daprodustat was primarily localized in the proximal region (0-2 cm) at 0.375-0.463 pg/mg at 1 month post-administration. The above findings are not only useful and beneficial for the purpose of doping control but also provide a better understanding of the mechanism of drug incorporation into horse hair.
Publication Date: 2023-07-24 PubMed ID: 37516063DOI: 10.1016/j.jpba.2023.115600Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Introduction:

  • Daprodustat is a medicine that inhibits hypoxia-inducible factor prolyl hydroxylase domain (HIF-PHD). Its role is to stimulate the production of red blood cells, which is helpful in treating anemia in humans.
  • If horses are given daprodustat, they are banned for life from participating in equestrian sports and horseracing by two major international organizations.

Objective:

  • The researchers wanted to investigate how long daprodustat and its byproducts can be detected in horse hair. This is important to monitor and prevent its misuse in horse sports. They compared this with how long the drug can be detected in plasma and urine.

Method:

  • Three thoroughbred mares were given daprodustat through the nose and throat (nasoesophageal administration) for three days.
  • Hair samples were taken from these horses over a 6-month period after giving them the drug. These samples were analyzed to detect the presence of daprodustat.

Results:

  • A month after giving the drug, daprodustat was found mainly in the hair closest to the skin. Over the next six months, this drug trace moved along the hair shaft, matching the growth rate of horse mane hair.
  • To understand how daprodustat gets into hair, 11 different parameters were studied, including how the drug behaves in the body (pharmacokinetics) and its physical and chemical properties. The major factors that influenced the drug’s presence in the hair were its maximum levels in the blood and its ability to dissolve in fats (lipophilicity). This suggests that daprodustat and similar drugs move from the bloodstream into the base of the hair through a natural process driven by concentration differences.
  • This study provides the first evidence that HIF stabilizers, like daprodustat, get into hair in this way.
  • Additionally, they compared how daprodustat is incorporated into horse hair with how another drug, roxadustat, is incorporated into human hair to gain insights into species differences.

Conclusion:

  • The findings help in doping control, ensuring fair play in horse sports by monitoring the misuse of drugs like daprodustat. It also gives insights into how drugs get incorporated into horse hair, which can be useful for both anti-doping efforts and broader veterinary science.

Cite This Article

APA
Ishii H, Shibuya M, Kusano K, Sone Y, Kamiya T, Wakuno A, Ito H, Miyata K, Yamada M, Leung GN. (2023). First evidence of the incorporation of daprodustat and other hypoxia-inducible factor stabilizers into equine hair by passive transfer based on segmental quantitative analysis. J Pharm Biomed Anal, 235, 115600. https://doi.org/10.1016/j.jpba.2023.115600

Publication

ISSN: 1873-264X
NlmUniqueID: 8309336
Country: England
Language: English
Volume: 235
Pages: 115600

Researcher Affiliations

Ishii, Hideaki
  • Drug Analysis Department, Laboratory of Racing Chemistry, 1731-2 Tsuruta-machi, Utsunomiya, Tochigi 320-0851, Japan; Department of Pharmaceutical Sciences, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan. Electronic address: h-ishii@lrc.or.jp.
Shibuya, Mariko
  • Drug Analysis Department, Laboratory of Racing Chemistry, 1731-2 Tsuruta-machi, Utsunomiya, Tochigi 320-0851, Japan.
Kusano, Kanichi
  • Veterinarian Section, Equine Department, Japan Racing Association, 6-11-1 Roppongi, Minato-ku, Tokyo 105-0003, Japan.
Sone, Yu
  • Veterinarian Section, Equine Department, Japan Racing Association, 6-11-1 Roppongi, Minato-ku, Tokyo 105-0003, Japan.
Kamiya, Takahiro
  • Equine Veterinary Clinic, Horse Racing School, Japan Racing Association, 835-1 Ne, Shiroi, Chiba 270-1431, Japan.
Wakuno, Ai
  • Equine Veterinary Clinic, Horse Racing School, Japan Racing Association, 835-1 Ne, Shiroi, Chiba 270-1431, Japan.
Ito, Hideki
  • Equine Veterinary Clinic, Horse Racing School, Japan Racing Association, 835-1 Ne, Shiroi, Chiba 270-1431, Japan.
Miyata, Kenji
  • JRA Equestrian Park Utsunomiya Office, 321-4 Tokamicho, Utsunomiya, Tochigi 320-0856, Japan.
Yamada, Masayuki
  • Drug Analysis Department, Laboratory of Racing Chemistry, 1731-2 Tsuruta-machi, Utsunomiya, Tochigi 320-0851, Japan.
Leung, Gary Ngai-Wa
  • Drug Analysis Department, Laboratory of Racing Chemistry, 1731-2 Tsuruta-machi, Utsunomiya, Tochigi 320-0851, Japan.

Conflict of Interest Statement

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Hideaki Ishii reports financial support was provided by Japan Racing Association.

Citations

This article has been cited 2 times.
  1. Ishii H, Shigematsu R, Takemoto S, Ishikawa Y, Mizobe F, Nomura M, Arima D, Kunii H, Yuasa R, Yamanaka T, Tanabe S, Nagata SI, Yamada M, Leung GN. Quantification of osilodrostat in horse urine using LC/ESI-HRMS to establish an elimination profile for doping control. Bioanalysis 2024;16(17-18):947-958.
    doi: 10.1080/17576180.2024.2385848pubmed: 39235065google scholar: lookup
  2. Checkouri A, Gheddar L, Arbouche N, Raul JS, Kintz P. Simultaneous detection of three hypoxia-inducible factor stabilizers-molidustat, roxadustat, and vadadustat-in multiple keratinized matrices and its application in a doping context. Drug Test Anal 2025 May;17(5):647-654.
    doi: 10.1002/dta.3771pubmed: 38992954google scholar: lookup